BioLineRx (BLRX) Research & Development: 2023-2025
Historic Research & Development for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to -$2.3 million.
- BioLineRx's Research & Development fell 4.54% to -$2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$8.4 million, marking a year-over-year increase of 20.56%. This contributed to the annual value of -$9.1 million for FY2024, which is 26.92% up from last year.
- According to the latest figures from Q2 2025, BioLineRx's Research & Development is -$2.3 million, which was down 43.31% from -$1.6 million recorded in Q1 2025.
- BioLineRx's 5-year Research & Development high stood at -$1.6 million for Q1 2025, and its period low was -$3.7 million during Q1 2023.
- Its 3-year average for Research & Development is -$2.6 million, with a median of -$2.5 million in 2024.
- Per our database at Business Quant, BioLineRx's Research & Development skyrocketed by 39.88% in 2024 and then fell by 4.54% in 2025.
- Over the past 3 years, BioLineRx's Research & Development (Quarterly) stood at -$3.1 million in 2023, then skyrocketed by 39.88% to -$1.9 million in 2024, then fell by 4.54% to -$2.3 million in 2025.
- Its Research & Development was -$2.3 million in Q2 2025, compared to -$1.6 million in Q1 2025 and -$1.9 million in Q4 2024.